VELPHORO

This brand name is authorized in United States. It is also authorized in Australia, Austria, Canada, Croatia, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, Singapore, Spain, UK.

Active ingredients

The drug VELPHORO contains one active pharmaceutical ingredient (API):

1	Sucroferric oxyhydroxide UNII 87PZU03K0K - FERRIC OXYHYDROXIDE
	Sucroferric oxyhydroxide is also known as a mixture of polynuclear iron(III)-oxyhydroxide (pn-FeOOH), sucrose and starches. Phosphate binding takes place by ligand exchange between hydroxyl groups and/or water and the phosphate ions throughout the physiological pH range of the gastrointestinal tract. Serum phosphorus levels are reduced as a consequence of the reduced dietary phosphate absorption.
	Read more about Sucroferric oxyhydroxide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VELPHORO Chewable tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V03AE05		V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
Discover more medicines within V03AE05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10230K, 10233N, 10250L
CA	Health Products and Food Branch	02471574
EE	Ravimiamet	1663264, 1663275, 1833432
ES	Centro de información online de medicamentos de la AEMPS	114943002
FI	Lääkealan turvallisuus- ja kehittämiskeskus	587946
FR	Base de données publique des médicaments	62955775
GB	Medicines & Healthcare Products Regulatory Agency	283924
HK	Department of Health Drug Office	66585
IL	מִשְׂרַד הַבְּרִיאוּת	7843
IT	Agenzia del Farmaco	043564018, 043564020, 043564032, 043564044, 043564057
LT	Valstybinė vaistų kontrolės tarnyba	1074207, 1074208, 1074209, 1074210, 1091491
NL	Z-Index G-Standaard, PRK	129496
PL	Rejestru Produktów Leczniczych	100326520
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67500001, W67500002
SG	Health Sciences Authority	14727P
US	FDA, National Drug Code	49230-645